177 related articles for article (PubMed ID: 25866152)
1. Reprogramming of human somatic cells by bacteria.
Ito N; Ohta K
Dev Growth Differ; 2015 May; 57(4):305-12. PubMed ID: 25866152
[TBL] [Abstract][Full Text] [Related]
2. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
3. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
[TBL] [Abstract][Full Text] [Related]
4. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
5. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
6. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation.
Chen T; Yuan D; Wei B; Jiang J; Kang J; Ling K; Gu Y; Li J; Xiao L; Pei G
Stem Cells; 2010 Aug; 28(8):1315-25. PubMed ID: 20521328
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells.
de Lázaro I; Bussy C; Yilmazer A; Jackson MS; Humphreys NE; Kostarelos K
Biomaterials; 2014 Sep; 35(29):8312-20. PubMed ID: 25002261
[TBL] [Abstract][Full Text] [Related]
9. [Current progress and application prospects of induced pluripotent stem cells].
Qin T; Miao XY
Yi Chuan; 2010 Dec; 32(12):1205-14. PubMed ID: 21513145
[TBL] [Abstract][Full Text] [Related]
10. Somatic Cell Reprogramming Informed by the Oocyte.
Gonzalez-Munoz E; Cibelli JB
Stem Cells Dev; 2018 Jul; 27(13):871-887. PubMed ID: 29737235
[TBL] [Abstract][Full Text] [Related]
11. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: evidence and implications.
Firas J; Liu X; Polo JM
Differentiation; 2014 Jul; 88(1):29-32. PubMed ID: 25281282
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cells from neonatal mouse cochlear cells.
Du D; Lou X
Differentiation; 2014; 87(3-4):127-33. PubMed ID: 24582575
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
15. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
López-González R; Velasco I
Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
[TBL] [Abstract][Full Text] [Related]
17. Five classic articles in somatic cell reprogramming.
Park IH
Yale J Biol Med; 2010 Sep; 83(3):135-7. PubMed ID: 20885901
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
19. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
Yamakawa H; Ieda M
Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
[TBL] [Abstract][Full Text] [Related]
20. Application of iPS cell technology to cancer epigenome study: uncovering the mechanism of cell status conversion for drug resistance in tumor.
Matsuda Y; Semi K; Yamada Y
Pathol Int; 2014 Jul; 64(7):299-308. PubMed ID: 25047500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
